| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.094 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |